Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Medexus Pharmaceuticals Inc (MDP.TO)

Medexus Pharmaceuticals Inc (MDP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Medexus Pharmaceuticals Inc 10 King Street East Suite 600 Toronto ON M5C 1C3 CAN

https://www.medexus.com P: 514-762-2626 F: 514-762-2336

Description:

Medexus Pharmaceuticals Inc is a specialty pharmaceutical company with a powerful North American commercial platform and a growing portfolio of inventive and rare disease treatment solutions. The company's focus is on the therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology.

Key Statistics

Overview:

Market Capitalization, $K 69,520
Shares Outstanding, K 24,652
Annual Sales, $ 113,054 K
Annual Net Income, $ -214 K
Last Quarter Sales, $ 26,303 K
Last Quarter Net Income, $ 110 K
60-Month Beta 2.32
% of Institutional Shareholders 2.99%

Growth:

1-Year Return 39.27%
3-Year Return 19.61%
5-Year Return -19.74%
5-Year Revenue Growth 34.84%

Per-Share Information:

Most Recent Earnings 0.00 on 11/07/24
Next Earnings Date 02/05/25
Earnings Per Share ttm 0.09
EPS Growth vs. Prev Qtr -94.40%
EPS Growth vs. Prev Year -58.21%
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 12/19/18

MDP.TO Ratios

Ratio
Price/Earnings ttm 21.89
Price/Earnings forward 15.31
Price/Earnings to Growth N/A
Return-on-Equity % 8.42%
Return-on-Assets % 1.47%
Profit Margin % -0.19%
Debt/Equity 1.13
Price/Sales 0.50
Price/Book 1.48
Book Value/Share 1.91
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar